Causes, etiology and diagnosis of acquired von willebrand disease: A prospective diagnostic workup to establish the most effective therapeutic strategies

Acta Haematologica

Volumn 121, Issue 2-3, 2009, Pages 177-182

  Sucker, Christoph ^a,e   Michiels, Jan Jacques ^c,d   Zotz, Rainer B ^b  

^a LaboMed Coagulation Center   (Germany)

^b Hemostasis Institute Düsseldorf   (Germany)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d Goodheart Institute   (Netherlands)

^e LaboMed Coagulation Center Berlin   (Germany)

Author keywords

Acquired von Willebrand disease; Benign monoclonal gammopathy; Immunoglobulin; Systemic lupus erythematosus

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; IMMUNOGLOBULIN; ARGIPRESSIN[1 DEAMINO]; AUTOANTIBODY; AUTOANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; VON WILLEBRAND FACTOR;

AUTOIMMUNE DISEASE; BLEEDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LYMPHOPROLIFERATIVE DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; THROMBOPLASTIN TIME; VALVULAR HEART DISEASE; VON WILLEBRAND DISEASE; ANTIBODY SPECIFICITY; BLOOD; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; HEART DISEASE; IMMUNOLOGY; METABOLISM; NEOPLASM;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DEAMINO ARGININE VASOPRESSIN; HEART DISEASES; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOPROLIFERATIVE DISORDERS; NEOPLASMS; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 67649660045     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000214858     Document Type: Review

References (23)

1. Simone J V, Cornet JA, Abildgaard CF: Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood 1968;31: 806-812.
2. Michiels JJ, Budde U, van der Planken M, van Vliet HHDM, Schroyens W, Berneman Z: Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management. Best Pract Res Clin Hematol 2001; 14:401-436.
3. Sucker C, Stockschlaeder M, Zotz RB, Scharf RE: Acquired von Willebrand syndrome. Dtsch Med Wochenschr 2004; 129: 1581- 1585.
4. Van Genderen PJ, Michiels JJ: Acquired von Willebrand disease. Baillieres Clin Haematol 1998; 11:319-330.
5. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE, Subcommittee on von Willebrand Factor: Acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 2000; 84: 345- 349.
6. Kumar S, Pruthi RK, Nichols WL: Estimation of prevalence and natural history of acquired von Willebrand disease (abstract). Haemophilia 2000;6:213.
7. Mohri H: Acquired von Willebrand syndrome: features and management. Am J Hematol 2006;81:616-623.
8. Federici AB: Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Hum Immunol 2005;66: 422-430.
9. Franchini M, Lippi G: Acquired von Willebrand syndrome: an update. Am J Hematol 2007;82:368-375.
10. Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, Budde U, van Vliet HHDM: Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematodes and in benign monoclonal gammopathy: therapeuic implications. Semin Thromb Hemost 2006;32: 577-588.
11. Michiels JJ, Schroyens W, Berneman Z, van der Planken M: Atypical variant of acquired von Willebrand syndrome in Wilms tumor: is hyaluronic acid secreted by nephroblastoma cells the cause? Clin Appl Thromb Hemost 2001;7:102-107.
12. Eikenboom JCJ, Tjernberg P, van Marion V, Heering KJ: Acquired von Willebrand syndrome: diagnostic problems and therapeutic options. Am J Hematol 2007;82:55-58.
13. Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HHDM: The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost 2006; 32:589-604.
14. Sadler JE: Aortic stenosis, von Willebrand Factor, and bleeding. N Engl J Med 2003;349: 323-325.
15. Sucker C, Feindt P, Scharf RE: Aortic stenosis, von Willebrand factor, and bleeding. N Engl J Med 2003;349:1773-1774.
16. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F, Bauters A, Decoene C, Goudemand J, Prat A, Jude B: Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-349.
17. Sucker C, Feindt P, Zotz RB, Stockschlaeder M, Scharf RE: Functional von Willebrand factor assays are not predictive for the absence of highest-molecular weight von Willebrand Factor mu ltimers in patients with aortic-valve stenosis. Thromb Haemost 2005;94:465-466.
18. Scheffold N, Hetzel GR, Cyran J, Sucker C: Heyde's syndrome - a critical review. Dtsch Med Wochenschr 2006; 131:1679-1684.
19. Sucker C: The Heyde syndrome: proposal for a unifying concept explaining the association of aortic valve stenosis, gastrointestinal angiodysplasia and bleeding. Int J Cardiol 2007;115:77-78.
20. Rauch R, Budde U, Koch A, Hofbek M: Acquired von Willebrand syndrome in children with patent ductus arteriosus. Heart 2002;88:87-88.
21. Tiede A, Priesack J, Werwitzke S, Bohlmann K, Oortwijn B, Lenting P, Eisert R, Ganser A, Budde U: Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study. J Thromb Haemost 2008;6:569-576.
22. Sucker C, Scharf RE, Zotz RB: Use of recombinant factor VIIa in inherited and acquired von Willebrand disease. Clin Appl Thromb Hemost 2008;15:27-31.
23. Moll S: Unusual bleeds, unusual clots. Haemostaseologie 2007;27:191-199.